Janux Therapeutics, Inc. (JANX): Shares Outstanding

Annual figures by period end, from SEC filings.

60.38M
As of 2025-12-31
61.08M
As of 2026-06-30
+13.2%
3-year compound annual growth
n/m
5-year compound annual growth
2020-12-31: 1.05M2021-12-31: 41.24M2022-12-31: 41.62M2023-12-31: 46.25M2024-12-31: 59.06M2025-12-31: 60.38M60.38M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3160.38M+2.2%2026-02-26, Balance as of period end
2024-12-3159.06M+27.7%2026-02-26, Balance as of period end
2023-12-3146.25M+11.1%2025-02-27, Balance as of period end
2022-12-3141.62M+0.9%2024-03-08, Balance as of period end
2021-12-3141.24Mn/m2023-03-10, Balance as of period end
2020-12-311.05Mn/a2022-03-18, Balance as of period end